The European session is seeing mostly slight gains today: the STOXX 600 is up about 0.1%, the DE40 is up 0.42%, the EU50 is up 0.29%, the FRA40 is up 0.27%, the IBEX 35 is up 0.70%, and the FTSE 100 is up 0.13%, while the ITA40 and SUI20 are edging lower. The main factor supporting sentiment remains hopes for the resumption of U.S.-Iran talks and a possible extension of the ceasefire, which is sustaining risk appetite after a weaker start to the week. However, investors are not pricing in a full de-escalation scenario, as the ceasefire’s expiration date approaches and the risk of oil supply disruptions continues to weigh, particularly on Europe’s more energy-intensive economies.
That is why today’s rebound is rather moderate and resembles selective unwinding of bearish positions more than a strong risk-on move. In the currency market, the dollar is strengthening slightly, with the USDIDX index up 0.25%, while EURUSD is down 0.23%, indicating that some capital remains on the defensive side of the market. Oil is holding up relatively well, with Brent and WTI prices rising by 1.08% and 0.99%, respectively, though the broader narrative continues to revolve around possible progress in peace talks. The best performers today are technology, utilities, energy, and financials, which are up 0.96%, 0.91%, 0.61%, and 0.59%, respectively.
Słabiej wyglądają consumer staples, healthcare i communication services.
Sector-specific changes in Europe regarding intraday returns. Source: Bloomberg Financial Lp
Company information:
-
Royal Unibrew is seeing sharp losses—more than 20%—following news that its license to bottle PepsiCo products in Denmark, Finland, and the Baltic states will expire at the end of 2028, a business that accounts for approximately 13% of the group’s net revenue.
-
Thales is under pressure following the release of its first-quarter results because, despite a 27% organic increase in defense orders to a total of €4.65 billion, the market noted that total orders fell short of the consensus estimate of nearly €4.85 billion. At the same time, Thales confirmed its full-year guidance, and sales rose to €5.32 billion, exceeding analysts’ expectations; thus, the market reaction appears to be more a case of profit-taking following the sector’s strong rally than a shift in the long-term trend.
-
Puig also remains in the spotlight following reports that Estée Lauder is working with JPMorgan on a financing package worth around €5 billion for a potential bid to acquire the Spanish group.
-
In London, Associated British Foods is also attracting attention after deciding to spin off Primark from its food business and list both companies separately on the London Stock Exchange.

Volatility in other major instruments. Source: xStation
BREAKING: U.S. sales above expectations!
Chart of the day 📈Bitcoin rebounds above $76k trying to reverse the trend (21.04.2026)
Economic calendar: German ZEW and US retail sales in macro focus 🔎
GBPUSD slightly up after stronger than expected UK labour market data
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.